Caption Management’s BeOne Medicines Ltd ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.97M Buy
+10,000
New +$3.24M 0.02% 697
2025
Q3
Sell
-15,000
Closed -$3.63M 2117
2025
Q2
$3.63M Hold
15,000
0.04% 508
2025
Q1
$4.08M Buy
+15,000
New +$3.51M 0.04% 457
2024
Q4
Sell
-58,900
Closed -$13.2M 1894
2024
Q3
$13.2M Buy
+58,900
New +$10.6M 0.21% 116
2024
Q1
Sell
-7,500
Closed -$1.35M 1738
2023
Q4
$1.35M Sell
7,500
-6,900
-48% -$1.25M 0.02% 734
2023
Q3
$2.59M Buy
+14,400
New +$2.85M 0.04% 515
2023
Q2
Sell
-16,800
Closed -$3.62M 1456
2023
Q1
$3.62M Buy
16,800
+1,800
+12% +$432K 0.07% 307
2022
Q4
$3.3M Buy
15,000
+11,600
+341% +$2.13M 0.05% 425
2022
Q3
$458K Sell
3,400
-11,600
-77% -$1.99M 0.01% 1087
2022
Q2
$2.43M Hold
15,000
0.03% 607
2022
Q1
$2.83M Hold
15,000
0.03% 631
2021
Q4
$4.06M Sell
15,000
-20,000
-57% -$6.75M 0.05% 532
2021
Q3
$12.7M Buy
35,000
+15,000
+75% +$4.9M 0.15% 178
2021
Q2
$6.86M Buy
+20,000
New +$6.62M 0.09% 288
2020
Q4
Sell
-10,500
Closed -$3.01M 1292
2020
Q3
$3.01M Buy
+10,500
New +$2.47M 0.07% 321
2020
Q1
Sell
-9,000
Closed -$1.49M 1118
2019
Q4
$1.49M Buy
+9,000
New +$1.5M 0.05% 417

Other funds holding ONC

Caption Management's ONC Position: Q1 2026 in Review

Caption Management reduced its BeOne Medicines Ltd (ONC) stake by 56% in Q1 2026, selling an estimated $946K and leaving 2,300 shares worth $683K. The position accounts for ﹤0.01% of the portfolio, ranked #1124.

Caption Management first reported a position in ONC in Q4 2021 and has held it in 7 quarters since. The position peaked at $15.1M in Q4 2022. 281 funds tracked by Wall St. Rank hold ONC as of Q1 2026.

  • Caption Management held 2,300 shares of BeOne Medicines Ltd worth $683K as of Q1 2026.
  • Caption Management sold 2,924 BeOne Medicines Ltd shares in Q1 2026, an estimated $946K.
  • BeOne Medicines Ltd made up ﹤0.01% of Caption Management's portfolio in Q1 2026, its #1124 holding.
  • Caption Management first reported a position in BeOne Medicines Ltd in Q4 2021 and has held it in 7 quarters since.
  • Caption Management's BeOne Medicines Ltd position peaked at $15.1M in Q4 2022.
  • 281 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.